Biosimilar Pricing and Competition: Lessons from the US, France and Germany Biosimilar pricing and the challenge of market sustainability Healthcare systems Read More »
Communicate the value How a critical assessment of company narratives helped to refine the strategy for a high-cost innovative therapy launch in oncology Read More
Communicate the value How engaging with affiliates enabled the development of a fully adaptable budget impact model to support successful launches across all Wave 1 markets Read More
Communicate the value How an interactive gene therapy budget impact model produced greater internal understanding and facilitated communication with external stakeholders Read More
Communicate the value How focusing on the operational elements of pricing strategy supported in-country teams to strengthen their approach to pricing incremental innovation Read More
Communicate the value How a DELPHI survey informed the key inputs of a health economic model to support the launch of a breakthrough specialty product Read More
